Loading clinical trials...
Loading clinical trials...
A Phase II Study of Isavuconazole Prophylaxis in Adult Patients With AML/MDS and Neutropenia
Conditions
Interventions
Isavuconazole
Locations
1
United States
M D Anderson Cancer Center
Houston, Texas, United States
Start Date
March 28, 2017
Primary Completion Date
August 10, 2020
Completion Date
August 10, 2020
Last Updated
October 26, 2021
NCT06303193
NCT05564390
NCT03050268
NCT06847867
NCT07320235
NCT05969860
Lead Sponsor
M.D. Anderson Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions